Increased risk of occupational trichloroethylene hypersensitivity syndrome at exposure levels higher than 15 mg/L of urinary trichloroacetic acid, regardless of whether the patients had the HLA-B*13:01 allele.


Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
12 2020
Historique:
received: 26 03 2020
revised: 18 06 2020
accepted: 17 07 2020
pubmed: 8 8 2020
medline: 12 1 2021
entrez: 8 8 2020
Statut: ppublish

Résumé

Occupational trichloroethylene (TCE) exposure can cause hypersensitivity syndrome (TCE-HS). The human leukocyte antigen (HLA)-B*13:01 is reportedly an important allele involved in TCE-HS onset. However, the threshold exposure level causing TCE-HS in relation to HLA-B*13:01 remains unknown. We conducted a case-control study comprising 37 TCE-HS patients and 97 age- and sex-matched TCE-tolerant controls from the Han Chinese population. Urine and blood of patients were collected on the first day of hospitalization, and those of controls were collected at the end of their shifts. Urinary trichloroacetic acid (TCA) was measured as an exposure marker, and end-of-shift levels in the patients were estimated using the biological half-life of 83.7 h. HLA-B genotype was identified using DNA from blood. Crude odds ratios (ORs) for TCE-HS in the groups with urinary TCA concentration >15 mg/L to ≤50 mg/L and of >50 mg/L were 21.9 [95% confidence interval (CI) 4.2-114.1] and 27.6 (6.1-125.8), respectively, when the group with urinary TCA ≤15 mg/L was used as a reference. The frequency of HLA-B*13:01, the most common allele in the patients, was 62.2% (23/37), which was significantly higher than 17.5% (17/97) in the TCE-tolerant controls, with a crude OR of 8.4 (3.1-22.6). The mutually-adjusted ORs for urinary TCA >15 to ≤50 mg/L, >50 mg/L, and for HLA-B*13:01 were 33.4 (4.1-270.8), 34.0 (5.3-217.1), and 11.0 (2.4-50.7), respectively. In conclusion, reduction of TCE exposure to ≤15 mg/L is required for TCE-HS prevention because urinary TCA concentration >15 mg/L showed increased risk of TCE-HS, regardless of whether the patients had the HLA-B*13:01 allele.

Identifiants

pubmed: 32758551
pii: S0013-9351(20)30867-7
doi: 10.1016/j.envres.2020.109972
pii:
doi:

Substances chimiques

HLA-B Antigens 0
Trichloroethylene 290YE8AR51
Trichloroacetic Acid 5V2JDO056X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109972

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Hailan Wang (H)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, 510300, Guangzhou, PR China. Electronic address: 896725998@qq.com.

Tamie Nakajima (T)

Department of Life and Health Sciences, Chubu University, 487-8501, Kasugai, Japan. Electronic address: tnasu23@med.nagoya-u.ac.jp.

Yuki Ito (Y)

Department of Occupational and Environmental Health, Nagoya City University Graduate School of Medical Sciences, 467-8601, Nagoya, Japan. Electronic address: yukey@med.nagoya-cu.ac.jp.

Hisao Naito (H)

Department of Public Health, Fujita Health University School of Medicine, 470-1192, Toyoake, Japan. Electronic address: naitoh@med.nagoya-u.ac.jp.

Na Zhao (N)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, 510300, Guangzhou, PR China. Electronic address: zhaonabmu@126.com.

Hongling Li (H)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, 510300, Guangzhou, PR China. Electronic address: honglinglee5@126.com.

Xinxiang Qiu (X)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, 510300, Guangzhou, PR China. Electronic address: zfyqxx@163.com.

Lihua Xia (L)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, 510300, Guangzhou, PR China. Electronic address: xialh@163.com.

Jiabin Chen (J)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, 510300, Guangzhou, PR China. Electronic address: cjb6666@126.com.

Qifeng Wu (Q)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, 510300, Guangzhou, PR China. Electronic address: rigewu@126.com.

Laiyu Li (L)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, 510300, Guangzhou, PR China. Electronic address: 13662533086@139.com.

Hanlin Huang (H)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, 510300, Guangzhou, PR China. Electronic address: huanghl@gdoh.org.

Yukie Yanagiba (Y)

National Institute of Occupational Safety and Health, 214-8585, Kawasaki, Japan. Electronic address: yanagiba@h.jniosh.go.jp.

Hongyung Qu (H)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, 510300, Guangzhou, PR China. Electronic address: hzlaoying@163.com.

Hiroshi Yatsuya (H)

Department of Public Health, Fujita Health University School of Medicine, 470-1192, Toyoake, Japan. Electronic address: yatsuya@fujita-hu.ac.jp.

Michihiro Kamijima (M)

Department of Occupational and Environmental Health, Nagoya City University Graduate School of Medical Sciences, 467-8601, Nagoya, Japan. Electronic address: kamijima@med.nagoya-cu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH